Announcement on Release and Pledge of Controlling Shareholder's Shares
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Release and Pledge of Controlling Shareholder's Shares
Filed with SSE · · 3 pages · Chinese
Release
Zhejiang Shapuaisi Pharmaceutical Co. Ltd. on 6ix
Earlier from Zhejiang Shapuaisi Pharmaceutical
- Announcement on the Pledge of Shares Held by the Controlling Shareholder
- Indicative Announcement on Change in Equity of Shareholder with Over 5% Shares Reaching 1%
- Announcement on Resolution of the 2024 Annual General Meeting
- Announcement on Progress in Sale of Equity of Wholly-owned Sub-subsidiary
- Announcement on Obtaining the "Notice of Approval for Drug Supplement Application" for Levofloxacin Eye Drops
Later from Zhejiang Shapuaisi Pharmaceutical
- Announcement on the Result of Shareholding Reduction by Shareholder through Call Auction
- Announcement on Reply to SSE Inquiry Letter on Ex Post Audit of the Company's 2024 Annual Report
- Announcement on Turnaround to Profitability for the 1st Half of 2025
- 2025 Semi-annual Report
- Announcement on Obtaining the "Drug Registration Certificate" for Terbutaline Sulphate Solution for Nebulization
Follow Zhejiang Shapuaisi Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Shapuaisi Pharmaceutical